Literature DB >> 23573378

Neuropsychiatric lupus.

Amal Alkhotani1.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. Involvement of the nervous system, either primary or secondary, is common in SLE, and 19 different neuropsychiatric clinical syndromes have been recognised in association with the disease. Several pathophysiological mechanisms have been implicated in the pathogenesis of neuropsychiatric SLE (NPSLE), including vasculopathy, autoantibodies, and cytokine-mediated tissue injury. Careful evaluation of the patient is required to rule out secondary causes before attributing the neurological symptoms to SLE. Treatment depends on the nature and severity of NPSLE syndrome.

Entities:  

Keywords:  Nervous system; Neuropsychiatric; Syndrome; Systemic lupus erythematosus (SLE)

Year:  2013        PMID: 23573378      PMCID: PMC3616793     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  38 in total

1.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 2.  Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.

Authors:  N Danchenko; J A Satia; M S Anthony
Journal:  Lupus       Date:  2006       Impact factor: 2.911

3.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

4.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

Review 5.  Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.

Authors:  Hiroshi Okamoto; Akiko Kobayashi; Hisashi Yamanaka
Journal:  J Biomed Biotechnol       Date:  2010-06-29

6.  Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.

Authors:  David P D'Cruz; Susana Mellor-Pita; Beatriz Joven; Giovanni Sanna; Judith Allanson; James Taylor; Munther A Khamashta; Graham R V Hughes
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

Review 7.  Myelitis in the course of systemic lupus erythematosus: review.

Authors:  Małgorzata Łukjanowicz; Marek Brzosko
Journal:  Pol Arch Med Wewn       Date:  2009 Jan-Feb

8.  Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population.

Authors:  T Heller; M Ahmed; A Siddiqqi; C Wallrauch; S Bahlas
Journal:  Lupus       Date:  2007       Impact factor: 2.911

9.  Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

Authors:  M T Herranz; G Rivier; M A Khamashta; K U Blaser; G R Hughes
Journal:  Arthritis Rheum       Date:  1994-04

Review 10.  Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management.

Authors:  Julia J Rhiannon
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

View more
  2 in total

1.  Clinical and laboratory manifestations of yemeni patients with systemic lupus erythematosus.

Authors:  Hassan A Al-Shamahy; Najla H M Dhaifallah; Yahya M Al-Ezzy
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

2.  PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus.

Authors:  Qing Luo; Zikun Huang; Jianqing Ye; Yating Deng; Le Fang; Xue Li; Yang Guo; Hong Jiang; Beihua Ju; Qingshui Huang; Junming Li
Journal:  Arthritis Res Ther       Date:  2016-02-11       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.